Organon Health & Healthcare | Organon Organon Launches U.S. Grant Programs and Listening Tour as Part of “Her Plan Is Her Power,” Reaching High-Need Communities To Help Reduce Unplanned Pregnancies Feb 20, 2024 7:30 AM ET Today, Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, embarks on the next phase of programming for “Her Plan is Her Power,” to improve access and outcomes related to unplanned pregnancy in the U.S. Flexible Media Releases Flexible Media Releases Organon Launches U.S. Grant Programs and Listening Tour as Part of “Her Plan Is Her Power,” Reaching High-Need Communities To Help Reduce Unplanned Pregnancies Feb 20, 2024 7:30 AM ET Organon Announces Formal Commitment to FP2030 To Help Prevent 120 Million Unintended Pregnancies in Low- and Middle-Income Countries Around the World Nov 14, 2022 7:30 AM ET Contact Organon
Health & Healthcare | Organon Organon Launches U.S. Grant Programs and Listening Tour as Part of “Her Plan Is Her Power,” Reaching High-Need Communities To Help Reduce Unplanned Pregnancies Feb 20, 2024 7:30 AM ET Today, Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, embarks on the next phase of programming for “Her Plan is Her Power,” to improve access and outcomes related to unplanned pregnancy in the U.S.
Organon Launches U.S. Grant Programs and Listening Tour as Part of “Her Plan Is Her Power,” Reaching High-Need Communities To Help Reduce Unplanned Pregnancies Feb 20, 2024 7:30 AM ET
Organon Announces Formal Commitment to FP2030 To Help Prevent 120 Million Unintended Pregnancies in Low- and Middle-Income Countries Around the World Nov 14, 2022 7:30 AM ET
